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Abstract 
Background. Hypertensive disorders during pregnancy have a detrimental effect on maternal 
and fetal outcomes, causing low birth weights, preterm births, and stillbirths. During pregnancy, 
hypertensive disorders affect up to 13% of all pregnancies and make up 10% of all maternal 
mortality in the United States (Centers for Disease Control and Prevention [CDC], 2019). 
Purpose. The purpose of this DNP project was to implement and standardize a high-risk 
obstetrical initiative for hypertensive mothers. Summary of Evidence. Data suggest that 
increased education and increased surveillance for high-risk obstetric patients decreases the need 
for obstetric services and decreases the evolution of hypertensive disorders during 
pregnancy. Objectives. This project aimed to decrease mother and infant morbidity and 
mortality by standardizing an FQHC’s high-risk OB initiative, which attempted to provide face-
to-face education with weekly telehealth follow-ups by a Registered Nurse in addition to regular 
obstetrical appointments. Interventions. Interventions included implementing a standardized 
enrollment and referral process, creating an electronic dashboard, and providing standardized in-
person education and follow-up monitoring by a Registered Nurse. Increasing education and 
weekly follow-up monitoring will assist in early recognition of hypertensive disease progression 
and timely patient-specific interventions. Outcomes. The program increased patient program 
enrollment by 940% and educated fifty-seven pregnant women on the signs and symptoms of 
preeclampsia and eclampsia. Implications for Practice. This program provides a framework to 
reduce perinatal and maternal mortality related to hypertensive disorders during pregnancy. This 
program also strives to empower women during their pregnancy to be active participants in their 
pre- and post- birth health. 
Keywords: hypertensive disorders, pregnancy, high-risk pregnancy, telehealth 
HYPERTENSIVE DISORDERS IN PREGNANCY 7 
Formalizing a High-Risk Obstetrical Initiative: 
Focus—Hypertensive Disorders 
Maternal and fetal outcomes have always been at the forefront of healthcare. Improving 
maternal health is a key priority for the World Health Organization (WHO, 2019), an 
organization dedicated to improving maternal health worldwide. According to WHO (2019), 
maternal mortality rates are unacceptable, with data showing that roughly 295,000 women 
worldwide died during their pregnancy or childbirth in 2017. WHO reports that many of these 
deaths are preventable with adequate care and services. Unfortunately, in the United States, 
maternal and fetal mortality and morbidity have continued to rise. The pregnancy-related 
mortality rate in the United States has increased from 7.2 per 100,000 live births in 1987 to 17.3 
in 2017 (Center for Disease Control and Prevention [CDC], 2020b). The rate of 17.3 deaths per 
100,000 live births is more than double the rate of other developed countries (CDC, 2020a). In 
countries like New Zealand, Norway, and the Netherlands, the maternal mortality ratio is 3 or 
less per 100,000 live births. More specifically, hypertensive disorders during pregnancy make up 
6.6% of maternal deaths in the United States. (CDC, 2020b). Hypertensive disorders during 
pregnancy include gestational hypertension, chronic hypertension (pre-existing), preeclampsia, 
and eclampsia. Hypertensive disorders affect one out of 17 pregnancies (CDC, 2020a). 
Hypertensive disorders during pregnancy are known for increased maternal and fetal mortality. 
Furthermore, hypertensive mothers are at significant risk for developing cardiovascular diseases 
after their pregnancy and more severe hypertensive disorders with subsequent pregnancies.   
Preeclampsia with severe symptoms has been identified as an independent risk factor to 
developing cardiovascular disease, including coronary artery disease, hypertension, 
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cerebrovascular accidents, and type 2 diabetes later in life (Paul et al., 2019). Preeclampsia alone 
has increased by 25% from 1987-2004 (American College of Obstetricians and Gynecologists 
[ACOG], 2020). Many of these hypertensive disorders can be treated before the disease process 
evolves into a life-threatening situation for mother and infant. However, for many patients, these 
disorders are not detected early or managed effectively because women cannot access care. Face-
to-face education, telehealth follow-up, increased communication, and surveillance of 
hypertensive patients during pregnancy are essential for detecting early signs and symptoms of 
hypertensive disorders and establishing patient-specific interventions. 
Statement of the Problem 
 Hypertensive disorders are increasing every year in the United States. According to the 
CDC (2019), the rate of hypertensive disorders has almost doubled from 1993 to 2014, affecting 
912 women per 10,000 live births. The number of women with pre-existing hypertension has 
also increased significantly, almost tripling from 1993 to 2014, affecting 167 per 10,000 births 
(CDC, 2019). Women in lower socioeconomic areas are at increased risk for developing 
hypertensive disorders due to having more associated risk factors such as obesity, type 2 
diabetes, sleep apnea, decreased awareness of signs and symptoms of hypertensive disorders, and 
lack of access to care. When women develop hypertensive disorders, their overall health is at risk 
during and after pregnancy. Currently, the only definitive treatment for preeclampsia is giving 
birth. Different modalities and treatments are needed to combat these alarming increasing rates 
and devastating maternal and perinatal outcomes. 
Background 
If not well controlled during pregnancy, hypertensive disorders place the mother and the 
neonate at significant risk for complications that include eclampsia, restriction of fetal uterine 
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growth, and fetal and maternal demise. Stillbirths are seven times more likely in hypertensive 
mothers than mothers who are not hypertensive. Hypertensive mothers progressing into 
preeclampsia is common, affecting 5%-8% of pregnancies in the United States (Bokslag et al., 
2016). Preeclampsia is defined as a systolic blood pressure >140 or diastolic blood pressure >90 
after 20 weeks gestation, with the presence of one of the following: proteinuria (>300mg/24hrs), 
maternal organ dysfunction, or uteroplacental dysfunction causing fetal growth restriction 
(Bokslag et al., 2016). Women with pre-existing (chronic) hypertension are twice as likely to 
progress into superimposed preeclampsia and be at increased risk for preterm births, perinatal 
death, miscarriage, and abruption than preeclamptic women without chronic hypertension 
(Sutton et al., 2018). Preeclampsia can occur quickly and suddenly, without notice. Therefore, 
constant feedback between the patient and the healthcare team is essential for better patient 
outcomes. Patients must also be aware of the signs and symptoms of preeclampsia and how to 
escalate care if preeclamptic symptoms occur. 
Significance 
 Hypertensive disorders are devastating because two individuals’ outcomes are affected, 
not just one. Additionally, the rate of hypertensive disorders is increasing at an alarming rate. 
According to Stevens et al. (2017), the diagnosis of preeclampsia, in particular, is rising faster 
than diabetes, Alzheimer’s, ischemic heart failure, chronic kidney disease, and obesity. Despite 
the high disease burden, current treatment options for preeclampsia are limited and the cost and 
effect of preeclampsia on our healthcare system are staggering. Preeclampsia is associated with a 
higher cost of birth, no matter the gestational age. Preeclampsia is also associated with premature 
births, which are significantly more costly for infants born at a lower gestation age (Stevens et 
al., 2017). In 2012, the total cost associated with preeclampsia in the U.S. healthcare system was 
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$1.15 billion for infants and $1.03 billion for mothers, a combined cost of $2.18 billion (Stevens 
et al., 2017).  
There is a disparity among women in the United States affected by hypertensive disorders 
and associated morbidity and mortality. Women with lower socioeconomic backgrounds and 
from neighborhoods below the poverty line are more likely to be associated with severe maternal 
mortality (Wang et al., 2020). Wang et al. (2020) also found that being of Hispanic ethnicity or 
Black race, and having lower education and no insurance were significant factors associated with 
higher maternal morbidity and mortality. Ethnic and racial minority women with multiple 
chronic diseases also experience a substantial increase in severe maternal morbidity (Wang et al., 
2020). As a result, a gap in care is created; with hypertensive disorders substantially increasing 
every year, more and more at-risk women could be fatally affected. 
Needs Assessment  
This high-risk OB quality improvement project took place at two Federally Qualified 
Health Center (FQHC) women’s health clinics. These clinics were located on two campuses in a 
south-central Texas metropolitan area. In addition to four Obstetrics-Gynecology (Ob-Gyn) 
physicians and one registered nurse (RN), there were six medical assistants (MAs), two licensed 
vocational nurses, one receptionist, and one office manager assigned to the two clinics. During a 
pre-project organization assessment period, it was observed that the Ob-Gyn providers 
inconsistently referred their high-risk hypertensive patients into the pre-standardized program, 
with the referral process consisting of the providers messaging the RN regarding eligible 
patients, when they remembered. It was also noted that because there was only one RN, the 
education and follow-up of the mothers was sporadic. Lastly, it was determined that the RN 
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documented the education and encounters in an Excel sheet and not the electronic health record 
(EHR). 
By formalizing this high-risk OB initiative focusing on hypertensive patients, it was 
determined that the patients would benefit from having an RN provide face-to-face education 
and frequent telephone follow-up, and this would facilitate the continuation of primary care after 
delivery. This project aimed to standardize the referral and enrollment process, provide 
consistent weekly follow-up monitoring and prompt face-to-face patient education after 
enrollment, and streamline patient documentation for the high-risk hypertensive OB initiative. 
This team-based OB-GYN project was based at the west campus clinic of the FHQC facility. The 
care team comprised two of the four Ob-Gyn physicians, the RN, a receptionist, and the practice 
manager. The two licensed vocational nurses participated in the team but were used by both the 
east and west campus clinics.  
Readiness for Change  
 The west campus clinic is intimately aware of the poor outcomes associated with elevated 
blood pressure during pregnancy and the epidemic of hypertensive disorders during pregnancy 
sweeping the country. Decreasing maternal and perinatal deaths and improving poor outcomes 
are at the forefront of the clinic’s practice. The providers and staff are very engaged and 
supported refining the program to make it more efficient. Once formalized, the clinic supported 
expanding this initiative throughout the FQHC healthcare system. The standardization of the 
hypertensive arm of this high-risk OB initiative provided data to improve the processes before 
the expansion. Consequently, the clinic was highly motivated to decrease any barriers and assist 
with implementing this project. Even though the staff, providers, and administration were 
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motivated to implement this project, change can be challenging, especially on a system and 
process level, which is the foundation of this project.   
Project Identification 
Purpose 
The purpose of this DNP project was to formalize and standardize a high-risk OB 
initiative, which included (a) a standardized enrollment and referral process, (b) in-person and 
telehealth education and follow-up monitoring by an RN, and (c) a standardized documentation 
process. This project focused on the high-risk hypertensive OB patient population but included 
other high-risk OB populations. This project aimed to decrease maternal and fetal morbidity and 
mortality related to hypertensive disorders during pregnancy.   
Outcomes  
The anticipated outcomes for the project included (a) increasing the ease with which 
patients were enrolled and how they were surveyed within the program, (b) growth in the number 
of patients enrolled in the program, and (c) ensuring that the providers and the nurse understood 
program procedures, education topics, and the documentation process. It was projected that 
patients would have an increased understanding of overall wellness, including the signs and 
symptoms of preeclampsia, and an appreciation of the importance of continued care after birth. 
Objectives 
 The objectives for this evidence-based project were: 
1. Educate 100% of providers, nurses, and MAs within the FQHC west campus Ob-Gyn
clinic regarding the obstetrical Initiative for high-risk hypertensive patients.
2. Enroll 95% of high-risk hypertensive OB patients in the obstetrical initiative for high-risk
hypertensive patients during the project implementation period.
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3. Close monitoring of 95% of the high-risk hypertensive OB patients during the project 
implementation period per American College of Obstetricians and Gynecologists 
(ACOG) guidelines. Criteria will be met if patients are seen or contacted by the RN 
within 3 days of referral to the obstetrical Initiative for high-risk hypertensive patients 
and receive at least one follow-up telehealth call per month up to the patient’s 6-week 
postpartum visit. 
4. Educate 100% of patients enrolled in the obstetrical Initiative for high-risk hypertensive 
patients on gestational hypertension and preeclampsia symptoms during the project 
implementation period. 
5. Screen 100% of patients enrolled in the obstetrical initiative for high-risk hypertensive 
patients using the ACOG Social Determinants of Health (SDoH) tool to identify needs 
during the project implementation period. 
6. Of those patients identified as having a positive SDoH screen, 95% will be provided 
resources and referral to social/community services. 
7. Refer 95% of patients enrolled in the obstetrical initiative for high-risk hypertensive 
patients for continued care after the 6-week postpartum visit. 
Summary and Strength of the Evidence 
Significant risk factors are associated with the development of preeclampsia. However, 
many women affected by preeclampsia are healthy nulliparous women with no known risk 
factors (ACOG, 2020). According to ACOG (2020), relying on maternal symptoms for 
preeclampsia can be problematic. Clinical signs and symptoms, such as headaches, are non-
specific and unreliable as a diagnostic criterion for preeclampsia with severe features (ACOG, 
2020). It is imperative that a diagnostic approach is followed when clinical signs are less severe 
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or not indicative of preeclampsia, especially if the gestational age is less than 20 weeks (ACOG, 
2020). Women diagnosed with preeclampsia (without severe features) and women with 
hypertension during pregnancy are managed similarly. However, to assume that hypertension 
during pregnancy is benign or is less relevant than preeclampsia is incorrect (ACOG, 2020). Of 
the women diagnosed with pregnancy-induced hypertension, 50% will develop a diagnosis that 
is consistent with preeclampsia (ACOG, 2020). Disease progression occurs more often when the 
hypertension diagnosis is made before 32 weeks of pregnancy (ACOG, 2020). What is required 
with both diagnoses is enhanced surveillance to promote good outcomes and decrease maternal 
and fetal risk. Screening methods, such as using biochemical markers and ultrasound to predict 
preeclampsia development, are inaccurate and unreliable (ACOG, 2020). Strategies and 
interventions to prevent preeclampsia have been studied for over 30 years, but no prevention 
intervention has been noted to decrease the risk of developing preeclampsia (ACOG, 2020). 
With regard to nutritional interventions, no evidence is noted to demonstrate the effectiveness of 
vitamin supplementation or sodium restriction for decreasing the risk of preeclampsia (ACOG, 
2020).  
The nursing profession plays a vital role in the team-based patient-centered care team, 
especially in a high-risk OB program. The RN enhances education, facilitates patient care 
coordination, and acts as a liaison between the provider and patient. Swan et al. (2006) suggest 
that the nurse’s most valuable asset is being the provider's eyes and ears. With a high-risk OB 
population where an increase in surveillance is needed, an RN providing telephone follow-up 
will only enhance team-based care, patient satisfaction, and maternal-fetal outcomes. Swan et al. 
found that in six studies that used RN-led technology-based or telephone interventions to 
promote education and provide counseling in heart-failure patients, outcomes improved. The 
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results included a reduction in patient emergency department visits, decreased hospital 
admissions, improved quality of life, improved self-care, and decreased mortality. In another 
study, Muender et al. (2000) found that increasing surveillance by telephone calls 1 to 2 days a 
week from 24 weeks until 37 weeks of gestation improved outcomes for the women and their 
babies. Weekly calls consisted of health assessments, access to food and meals consumed, and 
the use of prenatal vitamins. Muender et al. also concluded that women over the age of 18 had a 
44% reduction in preterm births (<37 weeks) and significantly showed the cost-benefit of a 
nursing intervention like telephone contact. Telephone contact is a relatively low cost and has 
been an effective intervention to complement other interventions, such as home health care and 
social support (Muender et al., 2000).  
Most of the country is still overcoming barriers and decreased access to care related to 
the COVID-19 pandemic. Mothers who are at risk for hypertensive disorders have had difficulty 
accessing care at the height of the pandemic. These mothers need to be seen and evaluated in a 
timely manner. The COVID-19 pandemic has helped open the door to making telemedicine more 
mainstream. Perrin et al. (2020) states that health systems worldwide are adopting telemedicine 
platforms and are employing them in new areas such as Ob-Gyn and primary care. The U.S. 
Centers for Medicare & Medicaid Services (CMS) has significantly increased access to 
telemedicine services, allowing for a broader range of providers to offer telemedicine services to 
reach more patients (Perrin et al, 2020). With advancing technology and the overwhelming need 
for a telemedicine platform, this widespread adoption by healthcare providers and healthcare 
systems will facilitate healthcare delivery well into the 21st century (Perrin et al, 2020).      
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Project Intervention Methods 
Systems Interventions  
Patients in the less formalized hypertensive high-risk OB program did not have a 
standardized enrollment process; patient data was also not easily accessible within the EHR. 
Often, high-risk hypertensive patients are overlooked or missed and not enrolled in the program. 
System project interventions to remedy this include (a) a standardized referral and enrollment 
process, (b) a standardized screening questionnaire, (c) a centralized dashboard for all patients 
enrolled in the program, and (d) a nursing template for documentation. The MA was responsible 
for the patient screening questionnaires, which identified eligible patients. If the MA noted a 
positive screen, they would notify the patient’s provider. The provider would “task“ the RN for 
patient enrollment, and the tasking tab within the EHR alerted the RN of the patient needing to 
be enrolled. Non-billable dummy codes were developed and implemented to identify high-risk 
patients and organize them within the dashboard. After applying the non-billable codes to the 
patient, the codes allowed the RN and provider to survey the patient throughout their pregnancy, 
identify what high-risk group they were in, and determine if their disease process resolved after 
delivery. If needed, a patient-centered discussion between the provider and RN occurred to 
determine patient enrollment. Then, the RN input the patient-specific enrollment and diagnosis 
codes, adding the patient to the view-only high-risk OB dashboard. The dashboard effectively 
allowed all staff to identify the enrolled patients quickly. The RN or provider also used the 
dashboard to assess the key components of care, such as the patient’s last visit, gestational age, 
previous vital signs and weight, and their assigned provider. The view-only dashboard updated 
automatically once the patient was added. 
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After enrollment, the RN had 3 days to initiate a telephone follow-up with the patient, if 
the patient was not evaluated in the clinic. A manual for high-risk OB patients was also created 
to use as a reference guide for the RN and staff. The manual included information on the referral 
and enrollment process, patient education, documentation, weekly follow-up calls, and 
community resources. This manual will assist with project sustainment. 
Patient Interventions 
Patient interventions included (a) face-to-face education regarding the signs and 
symptoms of preeclampsia, eclampsia, stroke, and overall wellness; (b) pre-and post-education 
questionnaires; (c) weekly follow-up telephone calls; (d) an SDoH screening with referral to 
services when indicated; (e) periodic evaluation of the patient for normotensive blood pressure 
until the 6-week postpartum appointment; and (f) facilitation of continued care after delivery 
through a primary care referral, if needed. The formalizing of the OB program for high-risk 
patients will assist with program expansion to all the FQHC women’s health clinics and assist 
new personnel for project sustainment.  
High-risk hypertensive patient face-to-face appointments were scheduled at the west 
campus. Weekly follow-up calls were conducted to assess new or continued SDoH needs and 
hypertensive disease progression signs and symptoms, and to reinforce education. Enrolled 
patients were evaluated by periodic chart audits. The RN offered continued care, additional 
resources, and further education at the 6-week postpartum follow-up appointment, if indicated. If 
a patient missed the 6-week postpartum appointment, the RN initiated a telephone follow-up call. 
Figure 1 outlines the system and patient interventions. 
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Figure 1 
High-Risk OB Initiative Flow Chart  
 
Theoretical Framework 
The Plan-Do-Study-Act framework was utilized for implementing this project, as this 
was a systems and patient intervention process. Adjustments were necessary throughout project 
implementation to meet patient and program objectives concisely and efficiently.   
Setting and Population  
The project was set at a FQHC system women’s health clinic on the west side of a south-
central Texas metropolis. Women enrolled in the program were diverse in ethnicity, 
socioeconomic status and background; all enrolled women met the criteria and were considered 
high-risk hypertensive patients.     
Barriers and Facilitators 
 Barriers to the project’s success included (a) limited staffing, RN vacancy, and patients at 
multiple clinic sites; (b) facilitating change in a large organization; and (c) staff resistance to 
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change and provider hesitancy. Having one RN during the project implementation created a 
significant barrier. A nurse at each site would have facilitated face-to-face education, increased 
patient surveillance, and decreased lag in enrolling patients. The organization’s RN vacancy 
decreased the ability to reach all enrolled patients promptly. The primary nurse position at the 
clinic became vacant during the implementation period, and a newly graduated nurse took her 
place. While this was initially a barrier, the newly hired nurse became a facilitator for this project 
and quickly became a project champion.  
The second barrier included working in a large organization. Interventions and changes to 
implementation strategies needed approval from the administration, which created lag time and 
delays in the project timeline.  
A third barrier was the staff’s resistance to change and provider hesitancy. The RN was 
primarily affected by the changes, and increased education was needed to initiate these changes. 
Provider hesitancy in referring patients and tasking the RN for enrollment was another barrier.   
Facilitators for the project included the Ob-Gyn director and the organization 
administration, who had a commitment to have this program succeed and provide high-risk 
women with quality team-based patient-centered care. Other facilitators included the partnership 
between UIW and the organization. This partnership facilitated the formalization and 
standardization of the organization’s program, enabling it to fulfil its mission of providing 
comprehensive high-quality healthcare to the San Antonio area..     
Evaluation Plan 
To evaluate the percentage of eligible hypertensive high-risk OB patients enrolled in the 
program, the number of eligible positive screens versus the number of patients enrolled in the 
program were assessed during the project implementation period. Evaluating patient’s blood 
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pressure trends was reviewed through patient chart audits and the patient’s dashboard data. A 
chart audit was done to assess the number of enrolled patients who received face-to-face 
education and weekly follow-ups. Pre- and post-questionnaires were collected to evaluate the 
effectiveness of patient teaching. The SDoH screening questionnaire was also assessed to 
determine the need for referrals to social or community services, followed by a chart audit to 
determine if the patient received resources. A chart audit also evaluated for nursing template 
documentation adherence and if the patients received education and referral to primary care 
postpartum.   
Ethical Consideration 
The ethical considerations for this project included voluntary participation and 
confidentiality. Patients involved with the project were informed that they could decline 
participation in education and follow-up monitoring and that doing so would not impact their 
eligibility for care. Personal and health-related information was needed to contact and assess 
high-risk patients. The concern for confidentiality regarding this sensitive information was 
mitigated by following HIPAA rules and regulations. The staff ensured that patient information 
was kept safe and not shared within the healthcare team in an unsecured manner. 
Results 
The implementation of this project took place between March 19 and June 14, 2021. The 
results for each of the objectives is shown in Figure 2. 
The first objective was to educate 100% of providers, nurses, and MAs within the two 
Ob-Gyn clinics. Project education was provided to 100% of the staff at each location, meeting 
this objective. Education was provided during the morning huddle, 1 week before the project 
implementation start date. One-on-one, in-person education to medical assistants, the RN, and 
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providers was also offered as needed throughout project implementation. All participating staff 
were receptive to program education. An educational email was sent to the providers and RN 
related to enrollment codes and program processes, in conjunction with the in-person education. 
This educational email provided a visual reference on how to enroll patients and the associated 
non-billable dummy codes. All providers and the RN acknowledged the educational email. 
Figure 2 
OB High-Risk Initiative Result 
 
Note. This figure shows the results of program initiative objectives.  
 
 
Enrolling 95% of eligible patients was the second objective. Eligible patients were 
defined as the number of positive patient screens that met the program criteria. Hypertension 
during pregnancy ICD-10 (International Classification of Diseases, Tenth Revision) code search 
was performed during the 11-week project implementation period for the two clinical sites. The 
search found that 90% of eligible women were enrolled in the program. The MAs were receptive 
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each patient who met the program criteria with positive screens daily. This objective was almost 
successful due to the efforts of the patient-centered healthcare team. 
The third objective was to have 95% of enrolled high-risk hypertensive OB patients have 
increased surveillance, defined by the RN making initial contact within 3 days of patient 
enrollment, either face-to-face or by phone call. Subsequently, the patient was to be contacted at 
least once a month up to the patient’s 6-week postpartum visit. This objective was partially met. 
A chart audit revealed that 100% of the enrolled patients received follow-up education at least 
once during the implementation period. However, the criteria of initial contact within 3 days was 
met by only 72% of the enrolled patients. Rapid enrollment of patients during the 
implementation period, multiple referring providers, two clinic sites, and only one RN were 
some of the factors that affected initial contact time. Even though this objective fell short, it did 
provide evidence to support this project, positive patient outcomes, and the need for a facilitating 
RN at each location. 
The fourth objective was to educate 100% of enrolled high-risk hypertensive patients on 
the signs and symptoms of preeclampsia and gestation or superimposed hypertension during 
pregnancy. Chart audits were used to assess if the enrolled patients received this education. The 
results found that 100% of the patients enrolled were educated not only on disease warning signs 
and progression but also when to call 911, seek healthcare services, and where the hospital was 
located. The pre and post-education questionnaires were audited to evaluate the impact of patient 
education. Of the eligible patients enrolled in the program, 40% received a pre-and-post 
questionnaire, and the average increase of knowledge was 15%. 
The fifth objective stated that all enrolled patients would be screened with the ACOG 
SDoH questionnaire. Due to the use of the PDSA cycle, this questionnaire was one of the last 
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implementation intervention cycles. For the total implementation period, only 50% of the 
patients enrolled in the program were screened.  
The sixth objective was to provide services to those patients with a positive SDoH 
questionnaire. A patient chart audit showed that, of the 29 patients screened, 15 patients were 
identified as having a positive screen. All 15 patients were provided with the identified needed 
resources.   
The seventh objective stated that 95% of the patients enrolled would be referred to 
primary care, if indicated at their 6-week postpartum visit. A chart audit showed that 100% of 
patients who kept their 6-week postpartum visit appointment identified as needing primary care 
services were referred.  
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Discussions 
Overall, this project was a success—the program assisted in empowering mothers to be 
active participants in their health during and after pregnancy. Formalizing and standardizing the 
program’s processes and the associated patient interventions were used to reach and educate the 
women to the fullest capacity. Specific strengths of this quality improvement project were 
formalizing and standardizing the clinic’s initial attempt at a program. New hires and the 
administration have access to the devised program manual to help them understand how the 
clinics educate and provide services to high-risk hypertensive mothers. A standardized RN 
documentation template is also available, readily found within the EHR, facilitating data mining. 
This data will assist in providing evidence on how effective this method of increased surveillance 
is in assisting the patients, how effective patient education is, and what other interventions are 
needed.  
The most significant addition resulting from this project was the development and 
implementation of the patient dashboard. This electronic dashboard allowed the providers, 
nurses, and other involved staff to evaluate trends and patient-specific data, such as the patient’s 
vitals, last appointment, next appointment, and when the previous RN visit occurred. The 
dashboard and associated enrollment codes allow this program to work in conjunction with the 
current EHR and provide sustainable, transparent monitoring for the staff and administration. 
This dashboard was transformational in ensuring that the health status of this at-risk population 
was closely observed during and after their pregnancy.  
Associate changes seen were the rapid increase of patients enrolled in the program and 
how receptive the patients were to participate in this program. It was noted that patients enjoyed 
having access to an RN, discussing their questions and concerns about their pregnancy, and 
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associated education. However, having two clinics with one RN managing both made 
implementing the patient interventions difficult. Creating the patient-nurse bond was found to be 
significantly more effective if done in person at initial contact. A trusting relationship is an 
essential component when forming the patient health care team. It can be postulated that when 
patients trust the RN and their healthcare team, they are more receptive to the education provided 
and more likely to sustain lifestyle changes. While literature specific to formalizing and 
standardizing a high-risk OB program focused on hypertensive OB patients was not found, 
increased patient satisfaction when RNs are active members of the patient care team in primary 
care is well documented (Swan, et al., 2006).  
Limitations 
Many limitations in project development and implementation were recognized. Working 
with a large organization can be challenging, especially when a systems change is needed. Large 
organizations require more time to access their system and arrange meetings with the appropriate 
people regarding specific system interventions like the dashboard. Even though the IT 
department was highly supportive and committed to this project, translating the needed patient 
information into a unified dashboard was challenging. Multiple revisions and re-evaluations were 
required to develop an effective patient dashboard, and the time required for each modification 
was significant. The time necessary for development and revision of the dashboard was not 
allocated in the project’s timeline, thus delaying some aspects of program implementation. A 
free flow of exchanges with IT during development would have facilitated a timely program start 
date and increased program clarity for staff and administration. 
           Another limitation was having only one RN to initiate this program. Having two RNs, one 
at each site, would have increased the program’s reach and increased face-to-face patient 
HYPERTENSIVE DISORDERS IN PREGNANCY  26 
education. Also, having an RN at both clinics would assist in championing the program, being an 
ever-present reminder for staff to continue screening patients, and for the provider to task 
eligible patients to the RN.  
           A third limitation was having the program snowball once the screening method was 
implemented. The program grew significantly in a short amount of time, and the associated 
workload was significant for one RN. Due to the increase in patients, the RN meeting project 
objectives, like making initial contact within 3 days of enrollment and weekly follow-up calls, 
was challenging. 
Recommendations 
 Recommendations to improve project sustainability and growth to reach as many high-
risk OB women include: 
1. Implement an RN at each clinic. Having an RN at each site will facilitate prompt 
face-to-face education and real-time patient enrollment. With multiple locations, the 
providers have to task the RN, and they, in turn, must resolve the tasking, enroll the 
patient, and make contact within 3 days. This process is delayed if the RN is at a 
different location than the patient. If there was an RN at each location, the patient 
could be seen the day they are enrolled. Also, the patient can have their questions 
answered in person and be provided with educational handouts. This initial in-person 
contact will also facilitate the patient’s trust in their health care team.  
2. Provide an area where the RN can educate the patient. Currently, a patient flow issue 
exists at both locations. After the provider sees the patient, the room must be cleaned 
and prepared for the next patient. If the RN needs to educate the patient, then room 
turnover is delayed. If the RN goes in before the provider, the provider must wait to 
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see the patient, causing them to run behind. A designated area would allow the RN to 
take their time when educating the patient and increase patient satisfaction. Also, 
having a designated area avoids interference with patient flow and ensures that the 
provider is not delayed and will continue to refer their patients to the program.  
3. Continue with IT developers to make changes as needed to the enrollment process 
and dashboard. As the program grows, changes will be needed to keep the enrollment 
processes and dashboard current and user-friendly.   
Sustainability  
 The sustainability of this program looks very promising. The medical director of the Ob-
Gyn clinics is invested in ensuring the program is sustainable, and her devotion will empower the 
staff to sustain this project by answering questions, providing feedback, and being available for 
unexpected issues. The medical director is also leading by example by advocating for project 
implementation and sustainment. Her leadership will empower the staff to take the time 
necessary to continue implementation and expand the program, even after project completion. 
The staff is also aware of how important this project is to the medical director and to patients and 
the avenues to take if any barriers arise during the sustainment phase. The medical director is 
readily available and has an open-door policy for any questions or issues related to this project.  
Having the medical director heavily invested also allows the administration and board of 
directors to realize the project’s impact and benefit to patients, while also meeting organizational 
goals, which include providing quality health care to an underserved population, providing 
preventative health, and keeping patients healthy. Having the administration’s supports provides 
an avenue for assistance if any barriers require administrative intervention. The administration is 
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very interested in expanding the program; their goal is to broaden the OB initiative to all clinics 
within the organization.   
Addition support for sustainability is evident in that project barriers are quickly 
identified, and suggestions from ancillary staff are well received. This project is heavily systems-
based and will need continuing modifications to the dashboard, enrollment codes, and processes 
in the future. The interprofessional relationship that has been built during the project will be a 
factor in its sustainability. The IT staff has been very receptive to assisting the medical director 
and ensuring the system interventions are running smoothly. Any questions related to IT are 
answered promptly.  
Implications for Practice 
A significant broad implication for practice is the importance of having a formalized 
high-risk OB initiative that increases the surveillance of mothers at risk for harmful outcomes 
due to hypertension during pregnancy and other high-risk conditions. This OB initiative 
increased surveillance and education and promoted active patient participation in their 
pregnancy. High-risk hypertensive mothers are more likely to have adverse outcomes than non-
hypertensive moms. This program empowered the patient by enhancing patient education on 
signs and symptoms of disease progression, having an RN available for questions, and providing 
applicable avenues for resources. This program will assist in recognizing disease progression 
earlier and improve mother and baby outcomes.   
A second more practical implication is the standardization of processes for a local 
initiative envisioned by the Ob-Gyn medical director for effective screening, enrollment, 
education, and monitoring of patients at high risk for maternal and infant morbidity and 
mortality. Upon starting the project, only 13 patients were enrolled in the high-risk OB initiative 
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encompassing three different high-risk groups. After implementing appropriate screening and 
enrollment strategies, enrollment expanded significantly. Specifically, high-risk hypertensive 
patient enrollment increased by 940% during the project implementation period. Success was 
possible due to the standardization and clear admission criteria defined in the high-risk program. 
The patient-centered care team was able to identify, assess, and enroll patients successfully. The 
participation of all members allowed for maximum enrollment, which optimized education, 
utilization, and implementation of resources. 
A third implication was the utilization of a patient-centered team-based approach. The 
clinic is recognized as an FQHC, which endorses a patient-centered model. The patient-centered 
approach has been recognized to assist with interprofessional communication, teamwork, 
decreased patient wait times, the provision of more patient education, self-management support, 
and the empowering of the patient to be an active member of their care team (Schottenfeld et al., 
2016). An essential first step is the clinic’s commitment to providing patient-centered team-
based care, which involves viewing the patient as a knowledgeable and equal partner in their care 
(Schottenfeld et al., 2016). This project implementation used this framework which encouraged 
the patients to become active in their care and empower them through education to enact and 
make sustainable lifestyle changes. Lifestyle changes will continue with their current pregnancy 
and after delivery and provide optimal health for future pregnancies. The American Nurses 
Association (2016) also endorses a patient-based team care approach and recognizes that the 
team’s most important member is the patient. As a result, the team member who guides patient 
care and related decision-making is the patient (American Nurses Associadtion, 2016). This 
quality improvement project focused on actively listening to the patient and on patient education, 
enabling the patient to make informed decisions during and after their pregnancy.   
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The Essentials of Doctoral Education for Advanced Nursing Practice fully outlines the 
role, scope, and leadership qualities of the doctoral-prepared nurse practitioner, regardless of 
specialty or primary focus (American Association of Colleges of Nursing [AACN], 2006). This 
quality improvement project fully enacted specific parts of the eight DNP Essentials, but two 
DNP Essentials were the cornerstone and basis for development and successful project 
implementation. These were Essential II: Organizational and Systems Leadership for Quality 
Improvement and Systems Thinking, and Essential VI: Interprofessional Collaboration for 
Improving Patient and Population Health Outcomes.   
           DNP Essential II: Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking allowed the conceptualization of new care delivery models which were 
feasible, promoted safety, and were deeply rooted in nursing sciences (AACN, 2006). Focusing 
on a target population allowed for an individualized patient education and care delivery model 
that kept the patient’s cultural and economic perspectives in mind (AACN, 2006). System 
improvements were made at a clinic level, enhancing sustainability and improving patient safety 
and healthcare outcomes (AACN, 2006).  
           DNP Essential VI: Interprofessional Collaboration for Improving Patient and Population 
Health Outcomes was instrumental in providing patient-specific care. The development of the 
dashboard would not have been possible without the IT department listening to the needs 
identified during this project. Also, the ongoing collaboration between the providers and nurse 
was essential to decipher patient goals, provide education, and resolve any barriers or potential 
barriers.   
HYPERTENSIVE DISORDERS IN PREGNANCY 31 
References 
American Association of Colleges of Nursing. (2006). The essentials of doctoral education for 
advanced nursing practice. https://www.aacnnursing.org/DNP/DNP-Essentials  
American College of Obstetricians and Gynecologists. (2020). Gestational hypertension and 
preeclampsia [Practice Bulletin No. 222]. Obstetrics and Gynecology, 135(6), e237-e260. 
https://doi.org/10.1097/AOG.0000000000003891  
American Nurses Association. (2016). Promoting patient-centered team-based health care (Issue 
Brief). https://www.nursingworld.org/~4af159/globalassets/docs/ana/ethics/issue-
brief_patient-centered-team-based-health-care_2016.pdf  
Bokslag, A., Van Weissenbruch, M., Mol, W. B., & De Groot, C. J. M. (2016). Preeclampsia; 
short and long-term consequences for mother and neonate. Early Human 
Development, 102, 47-50. https://doi.org/10.1016/j.earlhumdev.2016.09.007  
Centers for Disease Control and Prevention. (2019). Data on selected pregnancy complications in 
the United States. https://www.cdc.gov/reproductivehealth/
maternalinfanthealth /pregnancy-complications-data.htm 
Centers for Disease Control and Prevention. (2020a). High blood pressure during pregnancy. 
https://www.cdc.gov/bloodpressure/pregnancy.htmz 
Centers for Disease Control and Prevention. (2020b). Pregnancy mortality surveillance system. 
https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-
surveillance-system.htm#trends  
Muender, M. M., Moore, M. L., Chen, G. J., & Sevick, M. A. (2000). Cost-benefit of a nursing 
telephone intervention to reduce preterm and low-birthweight births in an African 
HYPERTENSIVE DISORDERS IN PREGNANCY 32 
American clinic population. Preventive Medicine 30(4), 271-276. https://doi.org/10.1006 
/pmed.2000.0637 
Paul, T. D., Hastie, R., Tong, S., Keenan, E., Hiscock, R., & Brownfoot, F. C. (2019). Prediction 
of adverse maternal outcomes in preeclampsia at term. Pregnancy Hypertension, 18, 75-
81. https://doi.org/10.1016/j.preghy.2019.09.004 
Perrin, P. B., Pierce, B. S., & Elliot, T. R. (2020). COVID-19 and telemedicine: A revolution in 
healthcare delivery is at hand. Health Science Reports, 3(2), Article e166. https://doi.org 
/10.1002/hsr2.166  
Schottenfeld, L., Petersen, D., Peikes, D., Ricciardi, R., Burak, H., McNellis, R., & Genevro, J. 
(2016). Creating patient-centered team-based primary care [White Paper]. Agency for 
Healthcare Research and Quality. https://pcmh.ahrq.gov/page/creating-patient-centered- 
team-based-primary-care  
Stevens, W., Shih, T., Incerti, D., Ton, T. G., Lee, H. C., Peneva, D., Macones, G. M., Sibai, B. 
M., & Anupam J. B. (2017). Short-term costs of preeclampsia to the United States health 
care system. American Journal of Obstetrics and Gynecology, 217(3), 237-248. 
https://doi.org/10.1016/j.ajog.2017.04.032  
Sutton, A. L., Harper, L, M., & Tita, A. T. (2018). Hypertensive disorders in pregnancy 
Obstetrics and Gynecology Clinics of North America, 45(2), 333-347. https://doi.org 
/10.1016/j.ogc.2018.01.012  
Swan, B. A., Conway-Phillips, R., & Griffin, K. F. (2006). Demonstrating the value of the RN in 
ambulatory care. Nursing Economics, 24(6), 315-322. https://www.researchgate.net /
publication/6538524_Demonstrating_the_value_of_the_RN_in_ambulatory_care. 
HYPERTENSIVE DISORDERS IN PREGNANCY 33 
Wang, E., Glazer, K. B., Howell, E. A., Elizabeth A., & Janevic, T. M. (2020). Social 
determinants of pregnancy—related mortality and morbidity in the United States. 
Obstetrics and Gynecology, 135(4), 896-915. https://doi.org/10.1097/AOG 
.0000000000003762 
World Health Organization. (2019). Maternal mortality. https://www.who.int/news-room/fact-
sheets/detail/maternal-mortality 
HYPERTENSIVE DISORDERS IN PREGNANCY 34 
Appendix A 
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subject research and does not require approval via the IRB process. Please use the IRB number NRR [21-
001 when inquiring about or referencing this determination. 
No further review of the project as proposed is required.  Should you determine at any point you wish to 
add additional elements to the project, please contact us before initiating those components, as this 
may impact the determination. 
For information regarding the IRB or the review process, please contact me at (210) 805-5885.  
Sincerely, 
Ana Hagendorf, PhD, CPRA 
Ana Hagendorf, PhD, CPRA 
Director, Office of Research and Sponsored Projects Operations 
Office of Research and Graduate Studies  
University of the Incarnate Word 
4301 Broadway, CPO 1216 
San Antonio, Texas 78209 
(210) 805-3036 
wandless@uiwtx.edu 
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Appendix B 
High-Risk OB Screening Questionnaire 
Have you ever been told you have diabetes by a doctor?  Yes  No 
Have you ever been told you have high blood pressure?  Yes  No 
Have you ever had a baby before 20 weeks, used   Yes  No 
Makena (progestin) injections or had a cerclage? 
Is BMI greater than 40? Yes No 
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Appendix C 
Nonbillable Dummy Codes 
AVAILABLE CODES
HOW TO ADD THE CODES?
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Appendix D 
SDoH Screening Questionnaire 
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Appendix E 
Hypertension during Pregnancy Pre-Post Questionnaire 
1. A blood pressure over 140/90 is considered hypertension
True    False 
2. High blood pressure may potentially cause harm to me or my baby.
True    False 
3. Having high blood pressure increases my chance of developing preeclampsia.
True False 
4. Shortness of breath, a headache that won’t go away, and sudden swelling of face or hands
are all signs of preeclampsia.
True False 
5. I should call my doctor or 911 if I experience any of the above symptoms.
True False 
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Appendix F 
Letter of Support 
